Table 4. Best ORR for evaluable subjects.
| Best overall response | n (%) | ||||
| Chidamide 20 mg + CHOP (n=8) | Chidamide 25 mg + CHOP (n=9) | Chidamide 30 mg + CHOP (n=9) | Chidamide 35 mg + CHOP (n=2) | Total (N=28) | |
| ORR, overall response rate; CR, complete response; CRu, unconfirmed complete response; PR, partial response; SD, stable disease; PD, progressive disease; CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone. | |||||
| Overall response | 8 (100) | 7 (77.8) | 9 (100) | 1 (50.0) | 25 (89.3) |
| CR or CRu | 4 (50.0) | 5 (55.6) | 7 (77.8) | 0 (0) | 16 (57.1) |
| PR | 4 (50.0) | 2 (22.2) | 2 (22.2) | 1 (50.0) | 9 (32.1) |
| SD | 0 (0) | 2 (22.2) | 0 (0) | 0 (0) | 2 (7.2) |
| PD | 0 (0) | 0 (0) | 0 (0) | 1 (50.0) | 1 (3.6) |